Adenovirus-Mediated Gene Transfer In Vivo to Cerebral Blood Vessels and Perivascular Tissue in Mice
- 1 July 1998
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 29 (7), 1411-1416
- https://doi.org/10.1161/01.str.29.7.1411
Abstract
Background and Purpose —Gene transfer to cerebral blood vessels has been accomplished in rats and dogs by injection of replication-deficient adenovirus into cerebrospinal fluid. In this study we examined transgene expression after injection of adenovirus into the cerebrospinal fluid of mice. Responses were observed in ICR mice and C57BL/6 mice, which are outbred and inbred strains, respectively. Methods —We injected replication-deficient recombinant adenovirus expressing nuclear targeted β-galactosidase, driven by either the Rous sarcoma virus promoter (AdRSV-βGal) or the cytomegalovirus promoter (AdCMV-βGal), into the cisterna magna of anesthetized ICR and C57BL/6 strains of mice. The brains were examined from 1 to 21 days after injection by chemiluminescent enzyme activity assay or histochemical staining. Results —After injection of AdRSV-βGal, expression of β-galactosidase in ICR mice peaked on day 7 and returned to basal by day 14. Expression of β-galactosidase in C57BL/6 mice was maximal on days 7 to 14 and was minimal by day 21 after injection of AdRSV-βGal. After injection of AdCMV-βGal in C57BL/6 mice, peak expression of transgene occurred on day 1 and was greatly diminished by day 3. Transgene expression was observed primarily on the ventral surface of the brain, with preferential expression in leptomeninges and adventitia along the major cerebral arteries of that region. Conclusions —Injection of recombinant adenovirus in the cisterna magna resulted in transgene expression in leptomeninges and perivascular tissue of cerebral blood vessels in two strains of mice. The CMV promoter elicited rapid but short-lived expression of the transgene, while the RSV promoter elicited slower, more sustained transgene expression. Expression of AdRSV transgene was prolonged in C57BL/6 mice compared with ICR mice. This approach for gene transfer may be useful to study cerebral vascular biology in genetically altered strains of mice.Keywords
This publication has 16 references indexed in Scilit:
- Immune Responses to Adenoviral Vectors During Gene Transfer in the BrainHuman Gene Therapy, 1997
- Regulatable Promoters for Use in Gene Therapy Applications: Modification of the 5′-Flanking Region of the CFTR Gene with Multiple cAMP Response Elements to Support Basal, Low-Level Gene Expression That Can Be Upregulated by Exogenous Agents That Raise Intracellular Levels of cAMPHuman Gene Therapy, 1996
- Complex Models for the Study of Gene Function in Cardiovascular BiologyAnnual Review of Physiology, 1994
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- MHC class I-cestricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirusesImmunity, 1994
- Expression of Escherichia coli β-Galactosidase and Rat HPRT in the CNS of Macaca mulatta Following Adenoviral Mediated Gene TransferExperimental Neurology, 1994
- Adenoviral vectors for gene transferAdvanced Drug Delivery Reviews, 1993
- A model system for in vivo gene transfer into the central nervous system using an adenoviral vectorNature Genetics, 1993
- Virus-induced autoantibody response to a transgenic viral antigenNature, 1990
- A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirusCell, 1985